Oric Pharmaceuticals, Inc. (ORIC): Net Income
-$129.47M
Year ended 2025-12-31
-$140.35M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$129.47M | n/m | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | -$127.85M | n/m | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | -$100.70M | n/m | 2025-02-18, From 2023-01-01 |
| 2022-12-31 | -$89.12M | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$78.72M | n/m | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | -$73.70M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$26.88M | n/m | 2022-03-21, From 2019-01-01 |
| 2018-12-31 | -$21.36M | n/a | 2021-03-23, From 2018-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | 2025-12-31 | -$129.47M | n/m |
| Alumis Inc. (ALMS) | 2025-12-31 | -$243.32M | n/m |
| Nkarta, Inc. (NKTX) | 2025-12-31 | -$104.08M | n/m |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | -$6.88M | n/m |
| Harrow, Inc. (HROW) | 2025-12-31 | -$5.14M | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$101.59M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $24.02M | n/m |
| Erasca, Inc. (ERAS) | 2025-12-31 | -$124.55M | n/m |
| MoonLake Immunotherapeutics (MLTX) | 2025-12-31 | -$227.32M | n/m |
Compare ORIC, ALMS, NKTX, STOK side by side · Screen every company in Pharmaceutical Preparations ↗